On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
On Mar. 25, 2020, University of Oxford researchers announced they had launched the world’s first COVID-19 government response…
On Mar. 25, 2020, Philips announced that it was increasing the production of certain critical care products and…
On Mar. 25, 2020, a mobility and epidemiological study from a global consortium of researchers, led by the…
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and…
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
On Mar. 25, 2020, CHF Solutions announced the use of its Aquadex therapy in the treatment of patients…
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
On Mar. 25, 2020, Mylan announced that it had waived its exclusive rights in the U.S. to distribute…
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
On Mar. 24, 2020, Resverlogix announced a Mar. 23, 2020 bioRxiv publication that has shown apabetalone to inhibit…
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
On Mar. 24, 2020, 3M and Ford Motor announced a partnership to increase the production of 3M’s powered…
On Mar. 24, 2020, Bausch Health announced it had donated medicines and health care products to assist in…
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
On Mar. 24, 2020, a new international project aims to enroll 500 COVID-19 patients to search for genetic…
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announceda research collaboration…